Timothy L Lash
Overview
Explore the profile of Timothy L Lash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
345
Citations
6865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lousdal M, Lash T, Flanders W, Brookhart M, Kristiansen I, Vedsted P, et al.
Epidemiology
. 2025 Jan;
PMID: 39855264
Background: Improvements in breast cancer therapy since the randomized controlled trials of mammography screening might have reduced the screening benefit. Most observational studies of mammography effectiveness would be confounded by...
2.
Bonnesen K, Heide-Jorgensen U, Christensen D, Christiansen C, Lash T, Hennessy S, et al.
JAMA Intern Med
. 2025 Jan;
185(3):314-323.
PMID: 39836391
Importance: No large randomized clinical trial has directly compared empagliflozin with dapagliflozin, leaving their comparative effectiveness regarding kidney outcomes unknown. Objective: To compare kidney outcomes between initiation of empagliflozin vs...
3.
Hernandez R, Critchlow C, Dreyer N, Lash T, Reynolds R, Sorensen H, et al.
Clin Pharmacol Ther
. 2025 Jan;
PMID: 39807817
A compilation of factors over the past decade-including the availability of increasingly large and rich healthcare datasets, advanced technologies to extract unstructured information from health records and digital sources, advancement...
4.
Nash R, Switchenko J, Ward K, Maliniak M, Collin L, Moubadder L, et al.
Am J Epidemiol
. 2025 Jan;
PMID: 39801014
Despite similar incidence rates, nationwide breast cancer mortality is 40% higher among non-Hispanic Black (NHB) than non-Hispanic White (NHW) women. The racial disparity persists even among women with early-stage disease,...
5.
Barberio J, Naimi A, Patzer R, Kim C, Hernandez R, Brookhart M, et al.
Am J Epidemiol
. 2025 Jan;
PMID: 39756369
No abstract available.
6.
Amin A, Waller L, Tate J, Lash T, Lopman B
Am J Epidemiol
. 2025 Jan;
PMID: 39745811
Rotavirus vaccine appears to perform sub-optimally in countries with higher rotavirus burden. We hypothesized that differences in the magnitude of rotavirus exposures may bias vaccine efficacy (VE) estimates, so true...
7.
Khorashad B, Kaabi O, Gardner M, Getahun D, Goodman M, Lash T, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39656806
Context: Although the increased burden of mental health problems among patients with classic 46,XX congenital adrenal hyperplasia (CAH) is well-documented, it remains unclear if this comorbidity is attributable to the...
8.
Zhang Q, MacLehose R, Collin L, Ahern T, Lash T
Epidemiology
. 2024 Nov;
36(2):237-244.
PMID: 39588976
Background: To account for misclassification of dichotomous variables using probabilistic bias analysis, beta distributions are often assigned to bias parameters (e.g., positive and negative predictive values) based on data from...
9.
Ahern T, Collin L, MacLehose R, Littenberg B, Haines L, Bonnett M, et al.
Epidemiology
. 2024 Nov;
PMID: 39575936
Background: A 2013 meta-analysis observed a protective association between overweight BMI (versus normal BMI) and all-cause mortality that was particularly strong in people aged ≥65. Estimates informing this meta-analysis were...
10.
MacLehose R, Ahern T, Collin L, Li A, Lash T
Cancer Epidemiol Biomarkers Prev
. 2024 Nov;
34(2):224-233.
PMID: 39540781
Background: We evaluated the impact of systematic bias due to loss of heterozygosity (LOH) and incomplete phenotyping in studies examining the relationship between CYP2D6 variants and breast cancer recurrence among...